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DiversityThe recent discovery of human T-lymphotropic virus type 3 (HTLV-3) in Cameroon highlights the
importance of expanded surveillance to better understand the prevalence and public health impact of this
new retrovirus. HTLV diversity was investigated in 408 persons in rural Cameroon who reported simian
exposures. Plasma from 29 persons (7.2%) had reactive serology. HTLV tax sequences were detected in 3
persons. Phylogenetic analysis conﬁrmed HTLV-1 infection in two individuals and HTLV-3 infection in a third
person (Cam2013AB). The complete proviral genome from Cam2013AB shared 98% identity and clustered
tightly in distinct lineage with simian T-lymphotropic virus type 3 (STLV-3) subtype D recently identiﬁed in
two guenon monkeys near this person's village. These results document a fourth HTLV-3 infection with a
new and highly divergent strain we designate HTLV-3 (Cam2013AB) subtype D demonstrating the existence
of a broad HTLV-3 diversity likely originating from multiple zoonotic transmissions of divergent STLV-3.Inc.Published by Elsevier Inc.In 2005, two new human T-lymphotropic viruses (HTLV) were
discovered in Cameroon, types 3 and 4 (HTLV-3 and HTLV-4),
doubling the number of known HTLVs, which previously included
only HTLV-1 and HTLV-2 (Blattner et al., 1984; Calattini et al., 2005;
Gessain et al., 2002; Khabbaz et al., 1993; Manns and Blattner, 1991;
Wolfe et al., 2005b). All four HTLV groups are believed to have
originated from cross-species transmission of simian T-lymphotropic
viruses (STLVs) to humans, though an STLV counterpart of HTLV-4 has
yet to be identiﬁed (Calattini et al., 2005; Gessain and de The, 1996;
Gessain and Mahieux, 2000; Gessain et al., 1996, 2002; Mahieux et al.,
1998; Nerrienet et al., 2001; Van Brussel et al., 1998; Vandamme et al.,
1998; Wolfe et al., 2005b). Recently, more robust phylogenetic
analysis of an STLV strain from a Macaca arctoides (MarB43) has
shown that this is a highly divergent virus distinct from other STLV-1/
HTLV-1 and has contingently been re-classiﬁed as STLV-5 (Liegeois
et al., 2008; Switzer et al., 2009; Van Dooren et al., 2005). Regardless
of suspected zoonotic origin, STLV in humans is typically called HTLV,
and both STLV and HTLV are known as the primate T-lymphotropic
viruses (PTLV). While HTLV-1 and -2 have spread globally to infectmillions of persons and cause disease in about 5% of infected persons
(Blattner et al., 1984; Gessain et al., 2002; Khabbaz et al., 1993;
Mahieux and Gessain, 2003; Manns et al., 1999; Roucoux andMurphy,
2004), very little is known about the epidemiology and public health
signiﬁcance of HTLV-3 and HTLV-4. Thus, additional studies are
required to determine the prevalence, geographic distribution, and
disease potential of these emerging retroviruses.
STLV-3 has a wide geographic and simian host range across Africa
and is composed of four subtypes based on phylogeographic clustering
of sequences obtained from infected simians (Meertens and Gessain,
2003; Meertens et al., 2002, 2003; Sintasath et al., 2009a,b). Subtype A
consists of STLV-3 from Papio hamadryas and Theropithecus gelada
baboons from East Africa (Eritrea and Ethiopia, prototype strains Ph969
and Tge2117, respectively) (Goubau et al., 1994; Van Dooren et al.,
2004b). Subtype B contains STLV-3 from monkeys (Cercopithecus,
Cercocebus, and Papio species) from West Central Africa (Cameroon,
Nigeria, Senegal; prototype strains CTO604, CTO-NG409, PPAF3,
respectively) (Goubau et al., 1994; Meertens and Gessain, 2003;
Meertens et al., 2002, 2003; Van Dooren et al., 2004b). Partial genomic
sequences from additional subtype B strains have been found in
Cercocebus agilis, Cercopithecus cephus, and Lophocebus albigena from
Cameroon (Courgnaud et al., 2004; Liegeois et al., 2008; Sintasath et al.,
2009a). Subtype C contains partially characterized viruses from
138 Rapid CommunicationCercopithecus nictitans from Cameroon (strains Cni217, Cni227,
Cni3034, and Cni3038) (Liegeois et al., 2008; Sintasath et al., 2009b;
VanDooren et al., 2001). Highly divergent STLV-3 recently found in two
guenons (Cercopithecus mona and C. nictitans) from Cameroon form
subtype D (strains Cmo8699AB, Cni7867AB, respectively) (Sintasath et
al., 2009a,b). Currently three HTLV-3 strains (2026ND, Pyl43, Lobak18)
have been identiﬁed, and all three are genetically related to the STLV-3
subtype B found in Cameroon (Calattini et al., 2005, 2009; Wolfe et al.,
2005b). HTLV-3(Pyl43) and HTLV-3(Lobak18) are nearly identical
sharing about 99% nucleotide identity to each other and to STLV-3
(CTO604), suggesting a common and recent ancestor (Calattini et al.,
2009). In contrast, HTLV-3(2026ND) is about 10% divergent from other
subtype B viruses (Switzer et al., 2006b).
To investigate further the distribution and diversity of HTLV, we
conducted a prevalence study in Cameroon approved by local ethics
committees, the Cameroon Ministry of Public Health, and the CDC
Institutional Review Board. In total, 408 persons living in eight villages
located in three separate forested areas of western and southeastern
Cameroon (Fig. 1) volunteered for participation in the study and
completed a questionnaire designed to collect information about
nonhuman primate (NHP) exposure and demographic data. From this
population, 402 persons donated blood specimens. Global positioning
systems (GPS) were used to map locations of the villages.
Plasma samples from these persons were tested for antibodies to
HTLV using the Vironostika HTLV-1/2 EIA (Biomerieux, Durham, N.C.)
that contains puriﬁed HTLV-1 and -2 viral lysates and a recombinantFig. 1. Geographic location of study sites in Cameroon. Upper panel, location of three major
showing proximity of the village of person Cam2013AB to the location where hunters collect
3D-infected person's village and STLV-3D-infected NHPs. White areas on map are cloud covHTLV-1 p21 Envelope (Env) protein. All reactive samples were tested
further by Western blot (WB) using a kit (HTLV Blot 2.4, Genelabs
Diagnostics, Singapore) that contains disrupted HTLV-1 virions, a gp21
recombinant envelope (Env) protein (GD21) common to both HTLV-1
and HTLV-2, and two HTLV-type-speciﬁc recombinant Env peptides,
MTA-1andK55,whichallowdifferentiationbetweenHTLV-1andHTLV-
2, respectively. Specimens that were reactive to the Gag (p24) and Env
(GD21) proteins were considered seropositive. Seropositive specimens
that were reactive to MTA-1 or K55 were considered HTLV-1-like or
HTLV-2-like, respectively. Seropositive samples not reactive to either
the MTA-1 or K55 peptides were considered HTLV-positive, but
untypeable. Specimens that were reactive to either p24 or GD21 alone
or in combination with other HTLV proteins were considered
indeterminate. These EIA and WB assays have been shown previously
to be capable of detecting antibodies to a broad range of PTLVs
(Meertens et al., 2002; Van Dooren et al., 2004b; Wolfe et al., 2005b).
DNAwas prepared from uncultured peripheral bloodmononuclear
cells (PBMCs) of all WB-reactive specimens, and its integrity was
conﬁrmed by ß-actin polymerase chain reaction (PCR) as previously
described (Wolfe et al., 2005b). All DNA preparation and PCR assays
were performed in a laboratory where only human specimens are
processed and tested according to recommended precautions to
prevent contamination. DNA specimens were ﬁrst screened with a
generic PTLV PCR assay capable of detecting and differentiating partial
tax sequences from each of the four major PTLV groups via
phylogenetic analysis (Sintasath et al., 2009a; Vandamme et al.,sites in Cameroon where the eight villages are located. Lower panel, topographical map
ed specimens from STLV-3D-infected monkeys. Small boxes indicate locations of HTLV-
er. Topomap courtesy of Google Maps.
139Rapid Communication1997; Wolfe et al., 2005b). Further resolution within each PTLV group
was obtained by phylogenetic analysis of LTR sequences PCR
ampliﬁed from PBMC DNA of persons with detectable tax sequences
using established primers and conditions (Meertens et al., 2001;
Sintasath et al., 2009a; Wolfe et al., 2005b). The primers SPL2Fn (5′
ACC WTG AGC CCS ARR TAT CCC C 3′) and LTRU5E (5′ CGC AGT TCA
GGA GGC ACC AC 3′) and SPL3Fn (5′ AGA GCC TYC CRI TGA MAA ACA
TTT C 3′) and 420PLTR (5′ GAA CGC GAC TCA ACC GGC GTG GAT 3′)
were also used to amplify PTLV-1 LTR sequences using standard
nested PCR conditions and a 45 °C annealing temperature. Additional
phylogenetic and molecular dating analyses using Bayesian Markov
Chain Monte Carlo (MCMC) and maximum likelihood (ML) inference
were performed as described recently (Sintasath et al., 2009b; Switzer
et al., 2009).
Zoonotic retroviral infection of primate hunters
The numbers of men and women in the study were almost equal
(male=200, women=208) and their ages ranged from 18 to 64
(average=36). Of the 408 persons, 339 (83%) reported contact with
NHP, including hunting, butchering, and keeping NHP pets. Of the 339
primate-exposed persons, 151 (45%) reported hunting, 335 (99%)
reported butchering, and 53 (16%) kept NHP pets. None of the
participants reported bite wounds. Three hundred eighty-ﬁve
participants identiﬁed themselves as being from Bantu ethnic groups,
23 individuals identiﬁed themselves as being from non-Bantu ethnic
groups including 21 participants who identiﬁed themselves as Baka,
and 2 as Hausa. Plasma samples from 29 persons (7.1%) were HTLV-1/
2 EIA- and Western blot (WB)-reactive with the following WB
proﬁles: HTLV-1 (n=3), HTLV-2 (n=2), HTLV-positive but untype-
able (n=6), and indeterminate (n=18).Fig. 2. HTLV Western blot proﬁles of HTLV-3D and HTLV-1 PCR-positive nonhuman
primate hunters from Cameroon. Cam2013AB is infected with HTLV-3D and
Cam1806LE and Cam1902AB are both infected with HTLV-1 variants. MTA-1 and K55
are the HTLV-1 and HTLV-2 type-speciﬁc envelope peptides, respectively. Reactivity to
additional HTLV-1 proteins and the serum control are shown on the left. CA, Gag capsid;
MA, Gag matrix; SU, Env surface protein; TM, Env transmembrane protein.PTLV tax sequences were detected in PBMC DNA of two HTLV-1-
seropositive persons (Cam1806LE and Cam1902AB) and one HTLV-
untypeable person (Cam2013AB) with moderate WB reactivity to
only gag (p24, p28) and recombinant envelope (GD21) proteins
(Fig. 2). Plasma from persons CAM1806LE and Cam1902LE reacted to
the HTLV-1 p19, p24, GD21 proteins and theMTA-1 peptides typical of
HTLV-1/STLV-1 infection (Fig. 2). Interestingly, both Cam2013AB and
Cam1902AB also showed reactivity to a protein slightly above the
GD21 band not seen in the negative or positive controls (Fig. 2). Of the
26 PCR negative persons, 14 and 20 individuals reported hunting and
butchering NHPs, respectively. Their ages ranged from 19 to 63 years
old and 69% were males. It is not uncommon to ﬁnd HTLV-
seroreactive and PCR-negative test results using specimens from
Africans, possibly due to cross-reactivity with malaria or other
antigens (Calattini et al., 2005, 2009; Mahieux et al., 2000b; Wolfe
et al., 2005b). Alternatively, the negative PCR results could be due to
low sensitivity of the generic primers to detect infections with low
viral loads or viral strains with sequence heterogeneity in the PCR
primer regions.
Remarkably, partial tax sequences from person Cam2013AB
clustered strongly within the PTLV-3 clade and were 100% identical
to those from a highly divergent STLV-3D we discovered recently in C.
mona and C. nictitans monkeys in Cameroon (strains Cmo8699AB,
Cni7867AB, respectively) (Sintasath et al., 2009a,b) (Fig. 3A).
Cam2013AB tax sequences clustered tightly with only the STLV-3D
subtypes and not other subtypes including STLV-3C for which only
partial tax-LTR sequences are currently available for comparison
(Fig. 3A). LTR sequences obtained from Cam2013AB shared 98%
identity to the two STLV-3D sequences, and all three sequences
clustered together with high bootstrap support in a distinct lineage in
the PTLV-3 phylogroup (Fig. 3B). Person Cam2013AB is a 32-year-old
Bantu male who reported using a gun and reported hunting crowned
monkeys (Cercopithecus pogonias), drills, and red-capped mangabeys
(Cercocebus torquatus). He also reported butchering these same NHPs,
and he is married with ﬁve children. Specimens were not available
from spouses or children to investigate person-to-person transmis-
sion in this study.
Phylogenetic analysis of tax (data not shown) and LTR sequences
(Fig. 4) from Cam1806LE and Cam1902AB conﬁrmed infection with
HTLV-1 (GenBank accession numbers, tax = GU391297, GU391298,
LTR= GU391299, GU3912300). Based on an alignment of 369-bp LTR
sequences, Cam1806LE clustered within the PTLV-1 subtype F clade
(Fig. 4) and shared approximately 99% sequence identity with STLV-1
from C. agilis, Lophocebus albigena, and C. nicitans reported recently in
Cameroon (Liegeois et al., 2008; Sintasath et al., 2009a). Person
Cam1806LE is a 35-year-old Bantumale who reported butchering and
hunting NHPs, including agile mangabeys (C. agilis), C. nictitans, C.
pogonias, C. cephus, chimpanzee, gorilla, and Colobus guereza.
Interestingly, LTR sequences from Cam1806LE clustered strongly
with two sequences from C. agilis (Cag9812NL and Cag9813NL)
identiﬁed recently (Sintasath et al., 2009a) that were located about
100 km south of Cam1806LE's village, supporting further a phylogeo-
graphic clustering of STLV-1 and HTLV-1. Cam1806LE is married with
ﬁve children. The Cam1902AB LTR sequence clustered in the newly
identiﬁed PTLV-1G clade containing mostly STLV-1 (Fig. 4) and is
closely related (97% identity) to HTLV-1(2810YI) also from Cameroon
but whose villages are about 250 km apart (Wolfe et al., 2005b).
Person Cam1902AB is a 48-year-old male Bantu who also reported
hunting and/or butchering NHPs, including gorilla, chimpanzee, drill
(Mandrillus leucophaeus), Preuss' colobus, Preuss' cercopithecus, De
Brazza monkeys, C. nictitans, and C. cephus. Cam1902AB also reported
keeping a drill as a pet for 3 years. He is married and has seven
children. Overall, our ﬁnding of sequences in Cam1806LE and
Cam1902AB with high homology to previously characterized STLV-1
sequences supports a possible recent transmission of STLV-1 to these
hunters. It is also possible that Cam1902AB is infected with an HTLV-1
Fig. 3. Identiﬁcation of a new HTLV-3 subtype by phylogenetic analysis of (A) partial tax and (B) LTR sequences. Bayesian andmaximum likelihood (ML) trees inferred from ﬁrst and
second codon positions (12cdp) of partial (628-bp) tax sequences and 200 million MCMC chains and a relaxed molecular clock. Posterior probabilities over ML bootstrap values are
provided at each node in the partial tax gene tree. (B) Neighbor joining (NJ) and ML trees inferred from 273-bp LTR sequence alignment and gave identical topologies. NJ over ML
boostrap values are shown at the major nodes of the LTR derived tree. HTLV sequences are in bold, STLV sequences are italicized.
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Fig. 4. Inferred phylogenetic relationships of PTLV-1 LTR sequences. Sequences from Cameroonian nonhuman primate hunters generated in the current study are boxed. Support for
the branching order was determined by 1000 bootstrap replicates using the neighbor-joining method; only values≥60% are shown. HTLV sequences are in bold, STLV sequences are
italicized.
141Rapid Communicationthat has crossed recently into humans from simians and is now
circulating in the general population. This alternate hypothesis is
based on the tight clustering of Cam1902AB LTR sequences with the
HTLV-1 (Cam 2810YI) LTR sequence in clade G rather than with STLV-
1 (Fig. 4). Identiﬁcation and analysis of additional HTLV-1 subtype G
sequences are needed to clarify this situation. Specimens were not
available from close contacts to evaluate person-to-person transmis-
sion of these viruses.
Characterization of the complete HTLV-3D proviral genome
By using uncultured PBMC DNA and a series of 12 overlapping
nested PCR ampliﬁcations (Fig. 5), as previously described (Sintasath
et al., 2009b; Switzer et al., 2006b), the entire proviral genome of
HTLV-3D(Cam2013AB) was obtained and was determined to be 8913
bp in length (GenBank accession number GQ463602). The primers
used to obtain the full-length HTLV-3D genome are provided in
Table 1. HTLV-3D(Cam2013AB) was about 23% divergent from
prototypical PTLV-3 subtypes, with the exception of STLV-3D
(Cmo8699AB) with which it shared 99.8% sequence identity across
the genome (Table 2) . Of the 34 nucleotide changes from STLV-3D
(Cmo8699AB), 8 occurred in the LTR but did not affect important
regulatory elements, 3 occurred in gag, 1 in protease, 11 in polymerase
(pol), 11 in envelope (env), and 1 in tax. These mutations resulted in
13 synonymous and 8 nonsynonymous amino acid substitutions. The
nonsynonymous changes were localized in pol (n=6) and env
(n=2). The organization of the HTLV-3D(Cam2103AB) genome was
similar to that of the PTLV-3 group and consisted of the regulatory andstructural genes gag, pro, pol, env, tax, rex all ﬂanked by LTRs (Fig. 5).
The LTR contained only two 21-bp repeat elements typical of PTLV-3
(Sintasath et al., 2009b; Switzer et al., 2006b, 2009).
Like STLV-3D, a putative antisense protein (ASP), reportedly
involved in viral replication and persistence, is present on the
negative RNA strand of HTLV-3D(Cam2013AB). In addition, all Tax
regulatory and functional motifs were conserved, including a
potential PDZ domain in the C-terminus, an important binding site
for Tax in mediating signal transduction and interleukin-2-indepen-
dent growth induction for T-cell transformation (Rousset et al., 1998;
Tsubata et al., 2005). These results suggest Tax3D interactions with
cellular regulatory pathways similar to those of both PTLV-1 and
PTLV-3 (Chevalier et al., 2006; Sintasath et al., 2009b; Switzer et al.,
2006b, 2009). All major structural, enzymatic, and regulatory gene
regions of HTLV-3d(Cam2013AB) are intact and suggest viral
replication and a predicted pathogenic potential comparable to
other PTLV-3s (Fig. 5) (Calattini et al., 2006; Chevalier et al., 2007;
Sintasath et al., 2009b; Switzer et al., 2006b). Like STLV-3D
(Cmo8699AB), a possible accessory protein (ORF-I) of unknown
function and 131 aa in length is present in HTLV-3D between env and
the 3′ LTR (Fig. 5, nucleotides 6559–6951).
Discovery of a new HTLV-3 and estimation of divergence dates
for PTLV-3D
Robust phylogenetic analysis of ﬁrst and second codon positions
(12cdp) of concatenated 4156-bp gag–pol–env–tax nucleotide
sequences using Bayesian andML inference, as described inmore detail
Fig. 5. HTLV-3D(Cam2013AB) (a) genomic organization and (b) schematic represen-
tation of PCR-based genomic walking strategy. (a) Non-coding long terminal repeats
(LTR), coding regions for all major proteins (gag, group-speciﬁc antigen; pro, protease;
pol, polymerase; env, envelope; rex, regulator of expression; tax, transactivator).
(b) Using a previously described PCR-based genomic walking strategy (Sintasath et al.,
2009b; Switzer et al., 2006b), the complete proviral sequence (8913 bp) was then
obtained by using PTLV-3D-speciﬁc primers located within each major gene region in
combination with generic PTLV primers (fragments 1–12). Amplicon sizes are
approximated with the solid bars.
142 Rapid Communicationelsewhere, (Sintasath et al., 2009b) conﬁrmed with strong statistical
support the high genetic similarity of STLV-3D(Cmo8699AB) andHTLV-
3(Cam2013AB) (Fig. 6). Both simian and human viruses clustered
tightly in a distinct lineage independent of other PTLV-3 (Fig. 6). These
results strongly support the discovery of a highly divergent HTLV-3 thatTable 1
Primers used to generate the complete HTLV-3D(Cam2013AB) proviral genome.a
Forward Primer (5′➔3′)
Regionb Primer Set Name Primer Sequencea
1. LTR Outer 8699LTRF1 1-TGACAGTGACAGCAAGCCCCAAGGCGA-27
Inner 8699LTRF2 12-GCAAGCCCCAAGGCGAGCCAC-32
2. LTR-gag Outer P5LF7 540-TCGGTCTCCTTTCTTTGGCGGTCT-563
Inner P5LF8 650-CCAGGGGCTCAGAAAGTAAAGGCT-673
3. gag-pol Outer P5LF6 391-GCACCTTCGCTTCTCCTGTCCTGG-414
Inner 8699P19F1 747-CACCGGAAATTCATACAGCCGTGC-769)
4. pol Outer 8699GF20 2093-ACCCCCCCAGTAAGCATCCAGGCG-2116
Inner 8699GF21 2338-AGATGTCCTCCAGCAATGCCAAAG-2361
5. pol Outer 2013F1 3104-CTTATGAAACCCTCCCTACC-3123
Inner 2013F2 3117-CCCTACCATACATGTCAAGCC-3137
6. pol-env Outer 2013F1 3104-CTTATGAAACCCTCCCTACC-3123
Inner 2013F3 3976-GGCCAGCTCCGGCGCCTGGCC-3996
7. env Outer PTLVENVF1 5040-AGACCAYCAACWCCATGGGTAA-5061
Inner 8699GP46NF1 5057-CTACATTTCTCAAAATGCGGATCCTCC-
5083
8. env Outer PTLVENVF1 5040-AGACCAYCAACWCCATGGGTAA-5061
Inner 2013F4 5959-GTCCCCTGTCCCTGATCTCTCC-5980
9. env-tax Outer OPH1F1 7080-AYCGGYGGTCCCASACTCC-7098)
Inner OPH1F2 7136-GCAGGAATAYACCACAGGCA-7155
10. tax Outer 2013F6 7391-CCTGGGACCCCATCGATGGAC-7411
Inner 2013F7 7408-TTTGGTAGGGATTTTTGTTAGGAAGG-
7429
11. tax Outer 2013F7 7408-GGACGCGTTGTCAGCTCGCCTC-7429
Inner 8699TF5 7673-GCACCATCGTGTGCTGATACCTC-7695
12. tax-LTR Outer 8699TF6 7750-CATCCGGACCAACTAGGGGCCTTC-7773
Inner 8699TF7 7776-AACAAAAATCCCTACCAAACGCTT-7799
a Positions of primers are given relative to HTLV-1ATK (GenBank accession J02029).
b Regions are numbered according to sequential genomic position shown in Fig. 6.we provisionally name HTLV-3D. Our taxonomic classiﬁcation is based
on guidelines used by the International Committee on Taxonomy of
Viruses (ICTV, http://www.ictvonline.org) and those published else-
where for deltaretroviruses using recommendations described for the
nomenclature of new HTLVs (Sintasath et al., 2009b; Switzer et al.,
2006b, 2009). Speciﬁcally, the subtype classiﬁcation is based upon
highly supported phylogenetic division of the subtypes and genetic
distances of at least 5% across the genome, as recently proposed
(Sintasath et al., 2009b). This classiﬁcation system is consistentwith the
phylogenetic relationships and genetic divergence seen between HTLV-
1 and HTLV-2 subtypes using only LTR sequences (Liegeois et al., 2008;
Mahieux et al., 1998, 2000a; Sintasath et al., 2009a; Switzer et al., 1995).
To gain insight into the evolutionary history of this new virus,
molecular dating of HTLV-3D was estimated using a Bayesian Markov
Chain Monte Carlo (MCMC) approach and a relaxed molecular clock
implemented in the BEAST software package (Drummond and
Rambaut, 2007), as previously described (Lemey et al., 2005;
Sintasath et al., 2009b; Switzer et al., 2006b, 2009). Calibration of
the relaxed molecular clock was done using the dates of 40,000–
60,000 years ago for the Melanesian HTLV-1 lineage (HTLV-1mel) and
15,000–30,000 years ago for the most recent common ancestor of
HTLV-2a/HTLV-2b native American strains as strong priors in a
Bayesian MCMC relaxed molecular clock method. These dates and the
corresponding HTLV sequences represent best estimates of human
colonization of Australo-Melanasia and the Americas, respectively.
The use of two calibration points has previously been shown to
provide more reliable estimates of PTLV substitution rates than a
single calibration date (Lemey et al., 2005; Switzer et al., 2009). The
upper and lower divergence times estimated from anthropological
data were used to deﬁne the interval of a strong uniform prior
distribution from which the MCMC sampler would sample possible
divergence times for the corresponding node in the tree. Using these
methods, a more recent common ancestor for HTLV-3D and STLV-3D
(Cmo8699AB) was inferred about 3600 years ago. The most recent
common ancestor (MRCA) of the PTLV-3 clade was inferred to have
occurred 115,688 years ago, which is consistent with dates reportedReverse Primer (5′➔3′)
Primer Sequence Product (bp)
P3GR6 1225-AYTGGTGGCTRCCWGGGGGCGGAAG-1201 1225
8699LTRR1 740-TAGGAGGGTGATCAATCCCGGACGA-715 729
PGGAGR1 1237-AIIGTCTGCATRAAYTGGGGGCT-1215 698
PGGAGR2 1181-TGCYTGIARRTCTTTCATYTGCCA-1153 532
P3GR1 2565-GATAGGGTTATTGCCTGGTCCTTGATA-2539 2175
P3GR1 2565-GATAGGGTTATTGCCTGGTCCTTGATA-2539) 1819
PGPOLR2 3206-RYRGGIGTICCTTTIGAGACCCA-3184 1113
PGPOLR2 3206-RYRGGIGTICCTTTIGAGACCCA-3184 869
2013R1 5136-GTGCACCGACTGGGGTCGCC-5117 2033
2013R3 4032-GTCACATTGGGTGGATGGACC-4022 916
2013R1 5136-GTGCACCGACTGGGGTCGCC-5117 2033
2013R2 5131-CCGACTGGGGTCGCCAGGGAC-5111 1156
PTLVENVR1 7256-CTYTGYCCRAAICCTGGRAARTGGGCTGA-7228 2217
8699GP46CR1 6004-GACGGCTCGGCGCTGACGA-5984 947
PTLVENVR1 7256-CTYTGYCCRAAICCTGGRAARTGGGCTGA-7228 2217
2013R4 7179-CAGAGACCACAACTGCGGGGAC-7158 1221
PH2R 7460-AAGGAGGGGAGTCGAGGGATAAGG-7437 381
2013VIR2 7437-GTATTGTAGAGGCGAGCTGA-7418 301
8699TR5 7794-TTTGGTAGGGATTTTTGTTAGGAAGG-7769 404
8699TR5 7794-TTTGGTAGGGATTTTTGTTAGGAAGG-7769 387
8699TF8R 7899-TGGTGCGCGGGTGGGCTGAAACAGG-7875 492
8699TR6 7849-GGATAAGTATGGCCCCTGTAC-7829 177
2013LF2R 8298-CTGGGTGCGAGACGTCCCCTAGACAG-8273 547
2013LF1R 8277-GACAGATGATTCAACTGTATGCCCTTTGGC-
8248
502
Table 2
Percent nucleotide and amino acid similarity of HTLV-3d(Cam2013AB) with other PTLV-3 subtypes.a,b
PTLV-3 (Subtype A) PTLV-3 (Subtype B) PTLV-3 (Subtype D)
STLV-3
(TGE-2117)
STLV-3
(PH969)
STLV-3
(CTO604)
STLV-3
(NG409)
STLV-3
(PPA-F3)
HTLV-3
(Pyl43)
HTLV-3
(Lok18)
HTLV-3
(2026ND)
STLV-3
(8699cmo)
Genome 77.3 77.3 77.5 77.4 77.5 74.8 77.7 77.4 99.8
LTR 73.9 74.4 75.9 75.6 74.7 76.1 76.6 75.2 98.9
gag 79.8 (88.6) 79.3 (87.9) 79.7 (88.6) 79.4 (87.7) 80.2 (88.6) 79.6 (88.4) 79.6 (87.8) 79.4 (87.4) 99.8 (99.8)
p19 78.0 (81.3) 79.6 (82.1) 77.0 (82.1) 76.6 (78.9) 76.6 (81.3) 76.8 (82.1) 77.3 (82.1) 75.3 (80.5) 100.0 (100)
p24 82.6 (95.8) 80.9 (93.5) 82.1 (95.3) 82.1 (96.3) 83.5 (96.3) 82.6 (95.8) 81.8 (94.9) 82.2 (93.9) 99.8 (100)
p15 75.7 (81.4) 73.4 (80.5) 77.7 (81.4) 76.8 (79.1 77.2 (80.2) 76.5 (79.1) 77.3 (80.2) 78.4 (81.4) 99.6 (100)
pro 71.9 (74.7) 72.9 (74.2) 74.3 (75.3) 73.4 (74.2) 72.6 (74.7) 73.5 (74.7) 73.9 (74.7) 73.8 (76.4) 99.8 (100)
pol 76.2 (81.5) 76.1 (82.0) 75.9 (81.1) 75.7 (81.4) 75.4 (81.80 75.8 (81.7) 76.1 (80.1) 75.8 (81.7) 99.6 (99.3)
envc 77.3 (84.4) 77.3 (83.2) 77.1 (83.4) 78.4 84.0) 78.3 (85.0) 77.3 (83.8) 77.4 (83.8) 78.7 (84.8) 99.5 (99.6)
SU 76.6 (80.4) 75.7 (78.5) 75.5 (79.5) 77.6 (80.1) 76.9 (80.8) 76.1 (79.8) 76.1 (79.8) 77.8 (80.8) 99.3 (99.6)
TM 78.5 (91.5) 80.1 (91.5) 79.5 (89.8) 79.8 (90.9) 80.6 (92.6) 79.7 (90.9) 79.8 (90.9) 80.4 (92.1) 99.8 (99.4)
rex 88.2 (73.7) 87.8 (72.1) 86.7 (69.4) 87.4 (72.7) 87.1 (71.6) 86.9 (69.9) 86.7 (69.4) 86.3 (71.0) 100.0 (100)
tax 84.6 (90.3) 84.6 (90.3) 83.5 (89.2) 83.7 (89.2) 83.7 (89.2) 83.7 (89.7) 83.9 (89.7) 82.6 (87.7) 99.9 (100)
a Amino acid similarities given in parentheses.
b Full-length genomes are not available from PTLV-3 subtype C for comparison.
c SU, surface; TM, transmembrane.
143Rapid Communicationpreviously (Sintasath et al., 2009b; Switzer et al., 2006b, 2009).
Similar divergence dates were obtained using an alignment of 628-bp
12cdp tax sequences that included all PTLV-3 subtypes, except the
mean substitution rates were slightly higher for the partial tax
alignment (5.92×10−7 vs. 5.41×10−7 substitutions/site/year).
Cameroon continues to be an epicenter for the emergence of a
broad range of divergent retroviruses (Calattini et al., 2005, 2009;
Wolfe et al., 2005b). All HIV-1 groups (M, N, and O) circulate in
Cameroon (Hahn et al., 2000), including the newly identiﬁed HIV-1
group P that is genetically similar to a simian immunodeﬁciency virus
(SIV) found in wild gorillas (Plantier et al., 2009). We describe here
the identiﬁcation of a new HTLV-3 in a Cameroonian primate hunter
that we call subtype D based on its high genetic relatedness to STLV-
3D discovered recently in two NHPs located within 20 km of theFig. 6. Identiﬁcation of a new HTLV-3 subtype by phylogenetic analysis of concatenated ga
positions of 4156-bp concatamer alignments and 200 millionMCMC chains and a relaxedmo
in the concatamer gene tree. HTLV sequences are in bold, STLV sequences are italicized.hunter's village documented by GPS mapping performed at the time
of both human and animal specimen collections (Fig. 1). These results
strongly support the phylogeographic clustering of STLV-3 and HTLV-
3, a ﬁnding consistent with those of STLV-1 and HTLV-1, re-afﬁrming
further the ease of transmission of STLVs to humans who live in
proximity to and are exposed to NHPs via hunting, butchering, or
keeping NHP pets (Calattini et al., 2005, 2009; Wolfe et al., 2005b).
Interestingly, none of the participants reported bite wounds following
NHP exposure, suggesting that cross-species transmission occurred by
contact with infected body ﬂuids possibly following a mucocutaneous
or other exposure. Our ﬁndings also demonstrate that HTLV-3 genetic
variation is driven by the diversity of STLV-3 existing in NHPs and
crossing into humans and that these zoonotic transmissions have
occurred on at least two separate occasions. Given the wide geneticg-pol-env-tax sequences. Bayesian and ML trees inferred from ﬁrst and second codon
lecular clock. Posterior probabilities over ML bootstrap values are provided at each node
144 Rapid Communicationdiversity and distribution of STLV-3 over the African biomes, the
historical exposure of Africans to NHPs, and the inferred ancient origin
of STLV-3, it is possible that more HTLV-3 variants will likely be found.
While HTLV-1-based screening tools such as EIA have been
successful in ﬁnding HTLV-3 and HTLV-4, the sensitivity of the
current screening assays to detect these viruses is currently unknown.
Likewise, HTLV-3 and HTLV-4 exhibit a broad range of reactivity in
HTLV-1-based WB tests, thus requiring PCR and sequence analysis for
conﬁrmation of infection (Calattini et al., 2005, 2009; Switzer et al.,
2006a; Wolfe et al., 2005b). Therefore, better diagnostic tools
incorporating HTLV-3 and HTLV-4 antigens are required to improve
serologic testing for these novel HTLVs and to determine whether
these infections are currently misdiagnosed as HTLV-1 or HTLV-2. If
so, the prevalence of HTLV-3 infections may be greater than currently
appreciated. The absence of HTLV testing of blood donors in many
African countries, including Cameroon, provides opportunities for
occult dissemination of both HTLV-3 and HTLV-4. Thus, to better
understand the public health signiﬁcance of these new HTLVs, studies
are needed to deﬁne their prevalence in the general population.
Our ﬁnding of a comparatively recent ancestor for STLV-3D and
HTLV-3D suggests a contemporary zoonotic transmission event
occurring in close geographic proximity in the forests of Cameroon,
most likely via exposures occurring at the hunter/primate interface.
This hypothesis is supported by both viruses having nearly identical
LTR sequences, which is the most divergent region of the PTLV
genome, suggesting a relatively short evolutionary history of HTLV-
3D. This high genetic similarity is consistent with that observed in
PTLV transmission pairs (Lal et al., 1993; Van Dooren et al., 2004a,b).
Even less divergence is seen in LTR sequences of both HTLV-3(Pyl43)
and HTLV-3(Lobak18) and STLV-3(CTO604) implying a more recent
primate-to-human transmission for these viruses than that for HTLV-
3D (Calattini et al., 2007, 2009; Meertens et al., 2002). The relatively
recent emergence of HTLV-3 and novel STLV-1-like virusesmay be the
result of further encroachment into the forests of Cameroon by
hunters and lumber companies that employ hunters to provide food
for their workers and the increased demand for bush meat (Wolfe
et al., 2005a). Additional studies are required to determine the
prevalence of HTLV-3, to investigate further the evolutionary history
of HTLV-3, and to evaluate its pathogenic potential and person-to-
person transmissibility, all of which will help to deﬁne the public
health signiﬁcance of this new human retrovirus. The use of GPS
deﬁned locations of infected animals and humans, as described here,
will be instrumental in understanding further the zoonotic transmis-
sion and evolutionary history of PTLVs and other pathogens.
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